Does poor glycemic control predict heart failure in diabetics?

Cardiology Review

Volumn 19, Issue 1, 2002, Pages 27-30

  Iribarren, Carlos ^a  

^a DIVISION OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C;

ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH MAINTENANCE ORGANIZATION; HEART FAILURE; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SEX DIFFERENCE; UNITED KINGDOM; UNITED STATES;

EID: 0036159023     PISSN: 10926607     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. 1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial
2. Diabetes mellitus in Egypt: Glycaemic control and microvascular and neuropathic complications
3. Glycemic control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus. The Finnish studies
4. Risk factors for coronary artery disease in non-insulin-dependent diabetes mellitus: United Kingdom Prospective Diabetes Study
5. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
6. Excess costs of medical care for patients with diabetes in a managed care population
7. The natural history of congestive heart failure: The Framingham Study
8. 1c measured by turbidimetric inhibition immunoassay
9. Role of diabetes in congestive heart failure: The Framingham Study
10. Diabetic cardiomyopathy
11. Modification of low-density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency
12. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery
13. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease